Marinus Pharmaceuticals Inc (MRNS)
0.532
0.00 (0.00%)
USD |
NASDAQ |
Jan 08, 16:00
0.532
0.00 (0.00%)
After-Hours: 20:00
Marinus Pharmaceuticals Research and Development Expense (Annual): 99.39M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Emergent BioSolutions Inc | 111.40M |
Traws Pharma Inc | 11.43M |
Viking Therapeutics Inc | 63.81M |
Rocket Pharmaceuticals Inc | 186.34M |
Axsome Therapeutics Inc | 97.94M |